Long-acting, broad-spectrum, water-soluble, cephalexin derivative.
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.